Literature DB >> 22810056

Evaluation of the national toxicology program report on carcinogens.

Brad Rodu1, Philip Cole, Jack S Mandel.   

Abstract

This study evaluates the National Toxicology Program's Report on Carcinogens program (RoCP) and compares it with the International Agency for Research on Cancer Monographs Program (IMP). We tracked agents classified in the RoCP since 1983 as known human carcinogens (A-List), or as reasonably anticipated to be human carcinogens (B-List). The first A-list included 24 agents, and twenty-four unique agents were added in the following 28years; twenty were listed by IMP as Group 1 (carcinogenic to humans) 7years before their A-list appearance. Group 1 also includes 30 or more agents eligible for, but not on, the A-list. The first B-list included 98 agents, and this increased to 185. Of these, 39 are in Group 2A (probably carcinogenic), and 122 are in Group 2B (possibly carcinogenic). Only 5% of the 204 agents ever on the B-list have been upgraded to the A-list. The RoCP is severely limited because it evaluates few agents and because its B-list does not distinguish between probable and possible human carcinogens. Further, it mislabels likely non-carcinogens as reasonably anticipated to be carcinogens. If the RoCP were terminated there would be no loss or delay of information available to scientific, public health and regulatory communities.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22810056     DOI: 10.1016/j.yrtph.2012.07.002

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  2 in total

1.  Necessity for a national carcinogen list in Korea, based on international harmonization.

Authors:  Jong Han Leem; Hwan Cheol Kim; Myungsook Park; Jung Ae Kim; Shin-Bum Kim; Mina Ha; Min Kyung Lim; Min-Kyeong Lim; Jeongseon Kim; Eun Young Park; Domyung Paek
Journal:  Environ Health Toxicol       Date:  2013-07-17

Review 2.  Genetic and Enzymatic Characteristics of CYP2A13 in Relation to Lung Damage.

Authors:  Radim Vrzal
Journal:  Int J Mol Sci       Date:  2021-11-14       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.